Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017533

Chief Financial Officer gave up 10,177 shares (to pay taxes)

  • Chief Financial Officer acquired 34,047 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2021-03-01 Option exercise +25,750 240,939 D
Ruffo Frank Chief Financial Officer 2021-03-01 Shares withheld for taxes −7,333 $24.06 $176,432 233,606 D
Ruffo Frank Chief Financial Officer 2021-03-02 Option exercise +8,297 241,903 D
Ruffo Frank Chief Financial Officer 2021-03-02 Shares withheld for taxes −2,844 $23.25 $66,123 239,059 D
Derivatives
Ruffo Frank Chief Financial Officer 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +116,000 116,000 D
Ruffo Frank Chief Financial Officer 2021-03-01 Grant or award · Restricted stock units +33,200 33,200 D
Ruffo Frank Chief Financial Officer 2021-03-01 Option exercise · Restricted stock units −25,750 51,500 D
Ruffo Frank Chief Financial Officer 2021-03-02 Option exercise · Restricted stock units −8,297 24,892 D
Loading xslF345X03/doc4.xml…